Author
Jing Wang
Recent research
- Health & Medicine
Background: Black and Hispanic individuals may experience a disproportionate burden of lipoprotein(a) [Lp(a)]-associated atherosclerotic cardiovascular disease (ASCVD) risk, and ASCVD-related mortality, yet remain underrepresented in cardiovascular (CV) clinical trials. Efficacy...
- Health & Medicine
Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
BackgroundPelacarsen, an antisense oligonucleotide, reduces serum levels of lipoprotein(a). However, the effect of pelacarsen on cardiovascular outcomes remains uncertain. MethodsWe conducted an international, randomized, placebo-controlled trial involving patients with preexisti...